SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AtheroGenics, Inc.{AGIX}-nasdaq -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (156)11/18/2005 10:47:57 PM
From: Miljenko Zuanic  Read Replies (2) | Respond to of 332
 
Not an expert, 1067 is only modified version of the old anti-oxidant. Will it work? Who knows?
Majority, if not all, animal studies were with very high drug dose, so data are irrelevant, imo.

Miljenko



To: tuck who wrote (156)11/19/2005 12:18:00 PM
From: kenhott  Read Replies (1) | Respond to of 332
 
It is not nice to call people freaks! Luckily I am not one of them.

I have been trading this stock for most of this year with the purpose of putting all the trading profits into naked puts. I have my full position and will just sit and see. I know this is the dumb and dumber version and what other people would do.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News